Back to search

Article

Small Molecule APOL1 Inhibitors as a Precision Medicine Approach for APOL1-mediated Kidney Disease

2024-04-08

Abstract excerpt

<title>Abstract</title> <p>Chronic kidney disease affects ~10% of people worldwide and there are no disease modifying therapeutics that address the underlying cause of any form of kidney disease. Genome wide association studies have identified the G1 and G2 variants in the <italic>apolipoprotein L1 </italic>(<italic>APOL1</italic>)<italic> </italic>gene as major contributors to a subtype of proteinuric kidney dis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b80118bf-13f7-5dd9-b545-af4168c670cb
DOI
10.21203/rs.3.rs-3922092/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Small Molecule APOL1 Inhibitors as a Precision Medicine Approach for APOL1-mediated Kidney DiseaseDOI 10.21203/rs.3.rs-3922092/v1
Select a neighboring publication to make it the new centre.